Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.
Polymegathism refers to variation in the size of corneal endothelial cells. In a healthy cornea, these cells are uniform, maintaining fluid balance and clarity. When size differences increase, it signals cell stress or loss. Factors include aging, contact lens use, surgery, or disease affecting endothelial function.
read more about polymegathism ...Special imaging such as specular microscopy measures endothelial cell size and density. A coefficient of variation above normal indicates polymegathism. Doctors use these readings to assess corneal tolerance to lenses or procedures. Regular monitoring helps track subtle changes over time.
Changes in size patterns reveal how the layer copes with stress. Lower counts or irregular shapes can affect clarity and fluid balance. Tracking these values warns clinicians when reserve is thinning. These insights support safer planning for surgeries or lens wear.
Mild cases rarely change vision, but severe endothelial loss can cause corneal swelling and blur. The surface may appear hazy or sensitive to light. Early detection allows timely adjustments in lens wear or treatment. Recovery depends on remaining healthy cells.
Chronic hypoxia from tight lenses, long term wear, or past inflammation can stress endothelial cells. Eye surgery and trauma also contribute. Aging naturally reduces uniformity, but lifestyle and fitting choices can slow decline. Regular eye exams catch early shifts.
Endothelial cells do not regenerate easily, so prevention is vital. Switching to high oxygen lenses or shorter wear times can limit further change. Medical advice may include drops for corneal protection. Stable readings are a good sign of control.
Is it painful? No, most people feel nothing.
Can it lead to blindness? Rarely, unless corneal failure develops.
How often should it be checked? Once a year for lens users or after eye surgery.
“Corneal Endothelial Polymegathism and Pleomorphism Induced by Daily-Wear Soft Contact Lenses.” Mutwaly RF, et al. (PubMed Central). https://pmc.ncbi.nlm.nih.gov/articles/PMC11582090/. Published 2024
“Corneal endothelial cells decline – A review of recent molecular biology concepts.” Domagala D, et al. Biomedicine & Pharmacotherapy (Elsevier). https://www.sciencedirect.com/science/article/pii/S0753332225007589. Published 2025
“Bioengineering Strategies for Corneal Endothelial Cell Therapy.” Choi Y, et al. Bioengineering (MDPI). https://www.mdpi.com/2306-5354/12/11/1162. Published 2025
“Biomaterial-based strategies for primary human corneal endothelial cell expansion.” Enkhbat M, et al. Biomaterials Science (Royal Society of Chemistry). https://pubs.rsc.org/en/content/articlehtml/2025/bm/d4bm00941j. Published 2025
“Fuchs’ Endothelial Corneal Dystrophy.” EyeWiki (American Academy of Ophthalmology). https://eyewiki.org/Fuchs%E2%80%99_Endothelial_Corneal_Dystrophy. Updated 2025